# Effects of Lutein Supplementation on Subclinical Atherosclerosis

Study · id `cardio:ct-nct01534533` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01534533](<https://clinicaltrials.gov/study/NCT01534533>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01534533

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 192 participants.

## Technical summary

Registry record NCT01534533. Randomized; quadruple masking; primary purpose prevention. Start 2010-06 (registry gives no type); primary completion 2011-06 (actual). Results posted on 2012-10-15.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 2/3
- Enrolled: 192 participants (enrolled count; ClinicalTrials.gov record NCT01534533, source copy `cardio:ctgov-nct01534533-2013-07-22`, retrieved 2026-10-31)
- Start date: 2010-06 (registry gives no type) (ClinicalTrials.gov record NCT01534533, source copy `cardio:ctgov-nct01534533-2013-07-22`, retrieved 2026-10-31)
- Primary completion: 2011-06 (actual) (ClinicalTrials.gov record NCT01534533, source copy `cardio:ctgov-nct01534533-2013-07-22`, retrieved 2026-10-31)
- Completion: 2012-06 (actual) (ClinicalTrials.gov record NCT01534533, source copy `cardio:ctgov-nct01534533-2013-07-22`, retrieved 2026-10-31)
- Results first posted: 2012-10-15 (ClinicalTrials.gov record NCT01534533, source copy `cardio:ctgov-nct01534533-2013-07-22`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT01534533, source copy `cardio:ctgov-nct01534533-2013-07-22`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01534533-2013-07-22`, retrieved 2026-10-31)

## The registry's words

- Brief title: Effects of Lutein Supplementation on Subclinical Atherosclerosis
- Condition: Carotid Atherosclerosis
- Condition: Carotid Intimal Medial Thickness 1
- Intervention (Dietary supplement): Placebo
- Intervention (Dietary supplement): Lutein group
- Intervention (Dietary supplement): Combination group
- Intervention (Dietary supplement): Normal lutein control group
- Lead sponsor: Peking University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry lists this organization as the lead sponsor: Peking University (`cardio:org-peking-university`)

## Provenance

Content hash: 00aa42f76fa2b4be01d9c0804504357c0d1344104c585ad70a4f9ed83be6b033
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
